These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 18271964)
1. Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances. Parr DG; Sevenoaks M; Deng C; Stoel BC; Stockley RA Respir Res; 2008 Feb; 9(1):21. PubMed ID: 18271964 [TBL] [Abstract][Full Text] [Related]
2. Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency. Parr DG; Dirksen A; Piitulainen E; Deng C; Wencker M; Stockley RA Respir Res; 2009 Aug; 10(1):75. PubMed ID: 19678952 [TBL] [Abstract][Full Text] [Related]
3. Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT. Dirksen A; Friis M; Olesen KP; Skovgaard LT; Sørensen K Acta Radiol; 1997 Sep; 38(5):826-32. PubMed ID: 9332238 [TBL] [Abstract][Full Text] [Related]
4. Influence of calibration on densitometric studies of emphysema progression using computed tomography. Parr DG; Stoel BC; Stolk J; Nightingale PG; Stockley RA Am J Respir Crit Care Med; 2004 Oct; 170(8):883-90. PubMed ID: 15271692 [TBL] [Abstract][Full Text] [Related]
5. Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency. Parr DG; Stoel BC; Stolk J; Stockley RA Thorax; 2006 Jun; 61(6):485-90. PubMed ID: 16537666 [TBL] [Abstract][Full Text] [Related]
6. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency. Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857 [TBL] [Abstract][Full Text] [Related]
7. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency. Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411 [TBL] [Abstract][Full Text] [Related]
8. Volume adjustment of lung density by computed tomography scans in patients with emphysema. Shaker SB; Dirksen A; Laursen LC; Skovgaard LT; Holstein-Rathlou NH Acta Radiol; 2004 Jul; 45(4):417-23. PubMed ID: 15323394 [TBL] [Abstract][Full Text] [Related]
9. Correlation between annual change in health status and computer tomography derived lung density in subjects with alpha1-antitrypsin deficiency. Stolk J; Ng WH; Bakker ME; Reiber JH; Rabe KF; Putter H; Stoel BC Thorax; 2003 Dec; 58(12):1027-30. PubMed ID: 14645966 [TBL] [Abstract][Full Text] [Related]
10. Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age. Piitulainen E; Montero LC; Nystedt-Düzakin M; Stoel BC; Sveger T; Wollmer P; Tanash HA; Diaz S COPD; 2015 Apr; 12(2):162-7. PubMed ID: 25280185 [TBL] [Abstract][Full Text] [Related]
11. Short-term reproducibility of computed tomography-based lung density measurements in alpha-1 antitrypsin deficiency and smokers with emphysema. Shaker SB; Dirksen A; Laursen LC; Maltbaek N; Christensen L; Sander U; Seersholm N; Skovgaard LT; Nielsen L; Kok-Jensen A Acta Radiol; 2004 Jul; 45(4):424-30. PubMed ID: 15323395 [TBL] [Abstract][Full Text] [Related]
12. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Dirksen A; Piitulainen E; Parr DG; Deng C; Wencker M; Shaker SB; Stockley RA Eur Respir J; 2009 Jun; 33(6):1345-53. PubMed ID: 19196813 [TBL] [Abstract][Full Text] [Related]
13. Assessment of regional progression of pulmonary emphysema with CT densitometry. Bakker ME; Putter H; Stolk J; Shaker SB; Piitulainen E; Russi EW; Stoel BC Chest; 2008 Nov; 134(5):931-937. PubMed ID: 18625668 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Stockley RA; Parr DG; Piitulainen E; Stolk J; Stoel BC; Dirksen A Respir Res; 2010 Oct; 11(1):136. PubMed ID: 20920370 [TBL] [Abstract][Full Text] [Related]
15. Repeatability of lung density measurements with low-dose computed tomography in subjects with alpha-1-antitrypsin deficiency-associated emphysema. Stolk J; Dirksen A; van der Lugt AA; Hutsebaut J; Mathieu J; de Ree J; Reiber JH; Stoel BC Invest Radiol; 2001 Nov; 36(11):648-51. PubMed ID: 11606842 [TBL] [Abstract][Full Text] [Related]
16. CT scan appearance, densitometry, and health status in protease inhibitor SZ alpha1-antitrypsin deficiency. Holme J; Stockley RA Chest; 2009 Nov; 136(5):1284-1290. PubMed ID: 19892672 [TBL] [Abstract][Full Text] [Related]
17. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG; Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936 [TBL] [Abstract][Full Text] [Related]